ArticleJIMD reports2016

Reduction of Plasma Globotriaosylsphingosine Levels After Switching from Agalsidase Alfa to Agalsidase Beta as Enzyme Replacement Therapy for Fabry Disease.

Ozlem Goker-Alpan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.